On the surface, the CMS competitive bidding process (CBP) has good intentions – lowering Medicare spending on durable medical equipment (DME). Forcing suppliers to bid low for contracts, with only winners getting paid, could possibly have negative and lasting effects on the nursing home industry.
Previously, a nursing home might choose to use boutique or a local mom-and-pop shop for supplies. Under the new rules (finalized Dec2025), they’ll likely be forced to choose from a few large-scale national distributors that won the remote item delivery contract.
Some of the unintended consequences can include:
This means some established smaller suppliers may go out of business or choose to adjust their business models.
The program does create a winner-take-all scenario for specific geographic areas and product categories. While this can achieve massive savings for taxpayers (billions of dollars), it undeniably changes the landscape from a free-access market to a contract-limited market.
For most standard medical supplies billed under Medicare Part B, nursing homes and their residents will be restricted to a specific list of contract winners. At this time, the categories include:
In its rush to establish the CBP, like many, we’re concerned that the administration may not have fully considered some ramifications. The CBP could increase financial strain as nursing homes and their suppliers face even tighter margins. Significantly diminishing the number of suppliers can lead to regional monopolies as smaller, mom-and-pop and niche providers get squeezed out. Artificially lowering prices can affect care quality as suppliers are forced to cut services, limit product options or hire less-experienced staff to generate competitive bids. Nursing homes may face potential access issues, especially in emergency situations.
While we understand the CMS’s goal to lower spending on DME, the unintended consequences of the CBP can potentially have negative effects on the industry in 2026 and beyond.